Aldeyra Therapeutics, Inc.
ALDX
$5.88
$0.254.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.31M | 11.69M | 11.89M | 11.74M | 10.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.31M | 61.15M | 60.12M | 49.64M | 43.05M |
| Operating Income | -53.31M | -61.15M | -60.12M | -49.64M | -43.05M |
| Income Before Tax | -50.62M | -57.70M | -55.85M | -44.80M | -37.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -50.62 | -57.70 | -55.85 | -44.80 | -37.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.62M | -57.70M | -55.85M | -44.80M | -37.87M |
| EBIT | -53.31M | -61.15M | -60.12M | -49.64M | -43.05M |
| EBITDA | -53.06M | -60.90M | -59.87M | -49.39M | -42.80M |
| EPS Basic | -0.85 | -0.97 | -0.94 | -0.75 | -0.64 |
| Normalized Basic EPS | -0.53 | -0.61 | -0.59 | -0.47 | -0.40 |
| EPS Diluted | -0.85 | -0.97 | -0.94 | -0.75 | -0.64 |
| Normalized Diluted EPS | -0.53 | -0.61 | -0.59 | -0.47 | -0.40 |
| Average Basic Shares Outstanding | 239.04M | 238.41M | 237.94M | 237.56M | 237.02M |
| Average Diluted Shares Outstanding | 239.04M | 238.41M | 237.94M | 237.56M | 237.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |